These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
905 related articles for article (PubMed ID: 27769315)
21. Bisphenol A stimulates the epithelial mesenchymal transition of estrogen negative breast cancer cells via FOXA1 signals. Zhang XL; Wang HS; Liu N; Ge LC Arch Biochem Biophys; 2015 Nov; 585():10-16. PubMed ID: 26363213 [TBL] [Abstract][Full Text] [Related]
22. cPLA2α mediates TGF-β-induced epithelial-mesenchymal transition in breast cancer through PI3k/Akt signaling. Chen L; Fu H; Luo Y; Chen L; Cheng R; Zhang N; Guo H Cell Death Dis; 2017 Apr; 8(4):e2728. PubMed ID: 28383549 [TBL] [Abstract][Full Text] [Related]
23. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition. Prasad CP; Chaurasiya SK; Guilmain W; Andersson T J Exp Clin Cancer Res; 2016 Sep; 35(1):144. PubMed ID: 27623766 [TBL] [Abstract][Full Text] [Related]
24. Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways. Yang L; Hou Y; Yuan J; Tang S; Zhang H; Zhu Q; Du YE; Zhou M; Wen S; Xu L; Tang X; Cui X; Liu M Oncotarget; 2015 Sep; 6(28):25755-69. PubMed ID: 26342198 [TBL] [Abstract][Full Text] [Related]
25. Aspirin-triggered resolvin D1 inhibits TGF-β1-induced EMT through the inhibition of the mTOR pathway by reducing the expression of PKM2 and is closely linked to oxidative stress. Liu Y; Yuan X; Li W; Cao Q; Shu Y Int J Mol Med; 2016 Oct; 38(4):1235-42. PubMed ID: 27573422 [TBL] [Abstract][Full Text] [Related]
26. Leptin promotes breast cancer cell migration and invasion via IL-18 expression and secretion. Li K; Wei L; Huang Y; Wu Y; Su M; Pang X; Wang N; Ji F; Zhong C; Chen T Int J Oncol; 2016 Jun; 48(6):2479-87. PubMed ID: 27082857 [TBL] [Abstract][Full Text] [Related]
27. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner. Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291 [TBL] [Abstract][Full Text] [Related]
28. Leptin regulation of the p53-HIF1α/PKM2-aromatase axis in breast adipose stromal cells: a novel mechanism for the obesity-breast cancer link. Zahid H; Subbaramaiah K; Iyengar NM; Zhou XK; Chen IC; Bhardwaj P; Gucalp A; Morrow M; Hudis CA; Dannenberg AJ; Brown KA Int J Obes (Lond); 2018 Apr; 42(4):711-720. PubMed ID: 29104286 [TBL] [Abstract][Full Text] [Related]
29. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways. Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264 [TBL] [Abstract][Full Text] [Related]
30. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation. Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608 [TBL] [Abstract][Full Text] [Related]
31. Soluble epoxide hydrolase inhibition ameliorates proteinuria-induced epithelial-mesenchymal transition by regulating the PI3K-Akt-GSK-3β signaling pathway. Liang Y; Jing Z; Deng H; Li Z; Zhuang Z; Wang S; Wang Y Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):70-5. PubMed ID: 25986738 [TBL] [Abstract][Full Text] [Related]
32. Heregulin-beta1 promotes metastasis of breast cancer cell line SKBR3 through upregulation of Snail and induction of epithelial-mesenchymal transition. Cheng L; Zha Z; Lang B; Liu J; Yao X Cancer Lett; 2009 Jul; 280(1):50-60. PubMed ID: 19269083 [TBL] [Abstract][Full Text] [Related]
33. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer. Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464 [TBL] [Abstract][Full Text] [Related]
34. Knockdown of TRIM47 inhibits breast cancer tumorigenesis and progression through the inactivation of PI3K/Akt pathway. Wang Y; Liu C; Xie Z; Lu H Chem Biol Interact; 2020 Feb; 317():108960. PubMed ID: 31981573 [TBL] [Abstract][Full Text] [Related]
35. [Metabolism enzyme controls cancer stemness]. Konno M; Doki Y; Mori M; Ishii H Nihon Rinsho; 2015 May; 73(5):745-50. PubMed ID: 25985625 [TBL] [Abstract][Full Text] [Related]
36. Adipocyte-derived IL-6 and leptin promote breast Cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression. He JY; Wei XH; Li SJ; Liu Y; Hu HL; Li ZZ; Kuang XH; Wang L; Shi X; Yuan ST; Sun L Cell Commun Signal; 2018 Dec; 16(1):100. PubMed ID: 30563531 [TBL] [Abstract][Full Text] [Related]
37. Metformin Inhibits Epithelial-to-Mesenchymal Transition of Keloid Fibroblasts via the HIF-1α/PKM2 Signaling Pathway. Lei R; Zhang S; Wang Y; Dai S; Sun J; Zhu C Int J Med Sci; 2019; 16(7):960-966. PubMed ID: 31341409 [No Abstract] [Full Text] [Related]
38. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer. Zhang X; Liu S; Zhu Y Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379 [TBL] [Abstract][Full Text] [Related]
39. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition. Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949 [TBL] [Abstract][Full Text] [Related]
40. [Novel mechanism for invasion and metastasis involving metabolic enzymes in intractable cancer cells]. Konno M; Hamabe A; Doki Y; Mori M; Ishii H Rinsho Ketsueki; 2015 Aug; 56(8):1059-63. PubMed ID: 26345567 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]